Covered recipient · General Payments record
ESHAMUMERENE ESIN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,721.38
- Reported across 229 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $333.05 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $77.43 | 4 |
| Lilly USA, LLC | $55.37 | 3 |
| GlaxoSmithKline, LLC. | $38.00 | 2 |
| PFIZER INC. | $31.88 | 2 |
| Astellas Pharma US Inc | $24.44 | 1 |
| Merck Sharp & Dohme Corporation | $21.37 | 1 |
| Abbott Laboratories | $19.13 | 1 |
| SHIELD THERAPEUTICS INC | $18.33 | 1 |
| Nevro Corp. | $17.04 | 1 |
| Acerta Pharma LLC | $16.29 | 1 |
| Exact Sciences Corporation | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.13 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125115712 | CMS |
| Astellas Pharma US Inc | $24.44 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139405597 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.29 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105308081 | CMS |
| Exact Sciences Corporation | $13.77 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114650110 | CMS |
| GlaxoSmithKline, LLC. | $18.25 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116307311 | CMS |
| GlaxoSmithKline, LLC. | $19.75 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116736538 | CMS |
| Lilly USA, LLC | $16.39 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134969541 | CMS |
| Lilly USA, LLC | $20.16 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134969353 | CMS |
| Lilly USA, LLC | $18.82 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134974554 | CMS |
| Merck Sharp & Dohme LLC | $21.37 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141857434 | CMS |
| Nevro Corp. | $17.04 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130776677 | CMS |
| Novo Nordisk Inc | $21.16 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096843591 | CMS |
| Novo Nordisk Inc | $16.90 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097647948 | CMS |
| Novo Nordisk Inc | $21.51 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097585658 | CMS |
| Novo Nordisk Inc | $17.86 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097802575 | CMS |
| PFIZER INC. | $13.80 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131971981 | CMS |
| PFIZER INC. | $18.08 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131081181 | CMS |
| SHIELD THERAPEUTICS INC | $18.33 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150126585 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.